Ampliphi Biosciences Corp (NYSEAMERICAN:APHB – Get Free Report)’s share price was up 1% during mid-day trading on Monday . The stock traded as high as $1.95 and last traded at $1.93. Approximately 23,983 shares traded hands during mid-day trading, a decline of 97% from the average daily volume of 842,200 shares. The stock had previously closed at $1.91.
Ampliphi Biosciences Stock Up 1.0%
The company’s fifty day simple moving average is $1.57 and its 200-day simple moving average is $1.90.
About Ampliphi Biosciences
AmpliPhi Biosciences Corporation, a biotechnology company, focuses on the development of therapies for antibiotic-resistant infections using bacteriophage-based technology. The company is involved in developing AB-SA01 for the treatment of staphylococcus aureus (S. aureus) infections; and AB-PA01 for the treatment of pseudomonas aeruginosa (P.
See Also
- Five stocks we like better than Ampliphi Biosciences
- Using the MarketBeat Dividend Tax Calculator
- Microsoft Stock Holds Steady as AI Drives Workforce Shift
- How to Effectively Use the MarketBeat Ratings Screener
- D-Wave Goes International With South Korea Partnership
- Unveiling The Power Of VWAP: A Key Indicator For Traders
- Payment Giants Slide on Stablecoin Buzz—Is Now the Time to Buy?
Receive News & Ratings for Ampliphi Biosciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Ampliphi Biosciences and related companies with MarketBeat.com's FREE daily email newsletter.
